 Johan Van Hove
Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperglycinemia, Nonketotic | 8 | 2019 | 46 | 3.490 |
Why?
| | DNA, Mitochondrial | 6 | 2021 | 187 | 2.190 |
Why?
| | Mitochondrial Diseases | 7 | 2024 | 79 | 1.980 |
Why?
| | Epilepsy | 7 | 2022 | 290 | 1.830 |
Why?
| | Mitochondrial Proteins | 5 | 2021 | 226 | 1.580 |
Why?
| | Aldehyde Dehydrogenase | 6 | 2022 | 134 | 1.520 |
Why?
| | Mutation | 16 | 2021 | 3457 | 1.410 |
Why?
| | Mitochondria | 6 | 2021 | 786 | 1.170 |
Why?
| | Pyridoxine | 5 | 2022 | 26 | 1.080 |
Why?
| | Growth Differentiation Factor 15 | 1 | 2024 | 35 | 0.940 |
Why?
| | Alagille Syndrome | 1 | 2024 | 37 | 0.940 |
Why?
| | Glycine | 4 | 2016 | 162 | 0.890 |
Why?
| | Cardiomyopathies | 2 | 2021 | 299 | 0.860 |
Why?
| | Corpus Callosum | 2 | 2019 | 57 | 0.850 |
Why?
| | Infant | 25 | 2021 | 8293 | 0.830 |
Why?
| | Leukoencephalopathies | 2 | 2019 | 32 | 0.820 |
Why?
| | Biliary Atresia | 1 | 2024 | 224 | 0.790 |
Why?
| | Ribosomal Proteins | 1 | 2021 | 68 | 0.790 |
Why?
| | Lysine | 4 | 2022 | 248 | 0.760 |
Why?
| | White Matter | 2 | 2019 | 115 | 0.750 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2024 | 280 | 0.730 |
Why?
| | Electron Transport Complex I | 1 | 2019 | 36 | 0.720 |
Why?
| | Energy Metabolism | 3 | 2015 | 767 | 0.690 |
Why?
| | Protein Biosynthesis | 1 | 2021 | 397 | 0.680 |
Why?
| | Thalamus | 1 | 2019 | 80 | 0.680 |
Why?
| | Magnetic Resonance Imaging | 10 | 2020 | 3174 | 0.660 |
Why?
| | Diseases in Twins | 1 | 2019 | 181 | 0.660 |
Why?
| | Leigh Disease | 3 | 2015 | 17 | 0.600 |
Why?
| | Vitamin B Complex | 2 | 2015 | 37 | 0.600 |
Why?
| | Infant, Newborn | 14 | 2021 | 5255 | 0.600 |
Why?
| | Mutation, Missense | 2 | 2016 | 300 | 0.590 |
Why?
| | Glycine Decarboxylase Complex | 1 | 2016 | 5 | 0.580 |
Why?
| | Glycine Dehydrogenase (Decarboxylating) | 1 | 2016 | 6 | 0.580 |
Why?
| | Aminomethyltransferase | 1 | 2016 | 8 | 0.580 |
Why?
| | 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2015 | 9 | 0.520 |
Why?
| | Acetyl-CoA C-Acetyltransferase | 1 | 2015 | 9 | 0.520 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2015 | 16 | 0.520 |
Why?
| | Mitochondrial Myopathies | 2 | 2023 | 5 | 0.510 |
Why?
| | Sulfurtransferases | 1 | 2013 | 9 | 0.480 |
Why?
| | Glutaredoxins | 1 | 2013 | 12 | 0.480 |
Why?
| | Arginine | 1 | 2015 | 249 | 0.480 |
Why?
| | Spasm | 1 | 2013 | 19 | 0.480 |
Why?
| | Neurodevelopmental Disorders | 1 | 2015 | 116 | 0.460 |
Why?
| | Genetic Variation | 2 | 2021 | 926 | 0.460 |
Why?
| | DNA Mutational Analysis | 8 | 2019 | 381 | 0.430 |
Why?
| | Channelopathies | 1 | 2011 | 5 | 0.410 |
Why?
| | Seizures | 3 | 2011 | 345 | 0.400 |
Why?
| | Amino Acids | 1 | 2015 | 465 | 0.400 |
Why?
| | Liver Diseases | 2 | 2013 | 282 | 0.400 |
Why?
| | Metabolic Diseases | 2 | 2010 | 103 | 0.400 |
Why?
| | Neurotransmitter Agents | 1 | 2011 | 76 | 0.390 |
Why?
| | Succinate-CoA Ligases | 1 | 2010 | 4 | 0.380 |
Why?
| | Brain Diseases, Metabolic | 1 | 2010 | 7 | 0.380 |
Why?
| | Humans | 44 | 2024 | 118974 | 0.380 |
Why?
| | Neurogenesis | 1 | 2011 | 105 | 0.370 |
Why?
| | Brain | 6 | 2019 | 2490 | 0.360 |
Why?
| | Ophthalmoplegia, Chronic Progressive External | 1 | 2009 | 3 | 0.350 |
Why?
| | Anticonvulsants | 2 | 2010 | 184 | 0.340 |
Why?
| | Holocarboxylase Synthetase Deficiency | 1 | 2008 | 2 | 0.340 |
Why?
| | Carbon-Nitrogen Ligases | 1 | 2008 | 3 | 0.340 |
Why?
| | Nutrition Therapy | 1 | 2009 | 32 | 0.340 |
Why?
| | Biotin | 1 | 2008 | 24 | 0.340 |
Why?
| | Transcription, Genetic | 1 | 2015 | 1323 | 0.330 |
Why?
| | Female | 26 | 2023 | 61565 | 0.330 |
Why?
| | DNA Helicases | 1 | 2009 | 131 | 0.320 |
Why?
| | RNA, Transfer, Glu | 1 | 2007 | 5 | 0.320 |
Why?
| | Male | 25 | 2023 | 57801 | 0.310 |
Why?
| | Proteins | 1 | 2013 | 938 | 0.310 |
Why?
| | Oxidative Phosphorylation | 2 | 2021 | 156 | 0.300 |
Why?
| | Practice Guidelines as Topic | 2 | 2013 | 1440 | 0.290 |
Why?
| | Child, Preschool | 11 | 2019 | 9491 | 0.280 |
Why?
| | Child | 15 | 2024 | 19129 | 0.280 |
Why?
| | GTP Cyclohydrolase | 1 | 2006 | 7 | 0.280 |
Why?
| | Paraparesis, Spastic | 1 | 2006 | 2 | 0.280 |
Why?
| | Dystonia | 1 | 2006 | 14 | 0.280 |
Why?
| | Molecular Sequence Data | 6 | 2015 | 2871 | 0.280 |
Why?
| | RNA, Transfer, Asp | 1 | 2005 | 2 | 0.270 |
Why?
| | Fatal Outcome | 3 | 2013 | 287 | 0.270 |
Why?
| | Parkinsonian Disorders | 1 | 2006 | 29 | 0.270 |
Why?
| | Tremor | 1 | 2006 | 46 | 0.270 |
Why?
| | Benzoic Acid | 1 | 2005 | 4 | 0.260 |
Why?
| | Fibroblasts | 3 | 2019 | 842 | 0.260 |
Why?
| | Heterozygote | 3 | 2017 | 262 | 0.260 |
Why?
| | Benzoates | 1 | 2005 | 40 | 0.260 |
Why?
| | Polymers | 1 | 2009 | 482 | 0.250 |
Why?
| | Eye | 2 | 2019 | 106 | 0.250 |
Why?
| | Amino Acid Sequence | 5 | 2015 | 2071 | 0.240 |
Why?
| | Brain Diseases | 3 | 2015 | 140 | 0.240 |
Why?
| | Glucose | 1 | 2009 | 953 | 0.240 |
Why?
| | Acyl-CoA Dehydrogenases | 1 | 2003 | 3 | 0.230 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2003 | 15 | 0.230 |
Why?
| | Genotype | 3 | 2019 | 1882 | 0.230 |
Why?
| | Phenotype | 5 | 2019 | 3003 | 0.220 |
Why?
| | Pedigree | 3 | 2019 | 485 | 0.210 |
Why?
| | Point Mutation | 2 | 2017 | 228 | 0.210 |
Why?
| | 2-Aminoadipic Acid | 2 | 2019 | 7 | 0.200 |
Why?
| | Adolescent | 10 | 2020 | 18480 | 0.190 |
Why?
| | Mitochondrial Encephalomyopathies | 1 | 2020 | 8 | 0.190 |
Why?
| | External Capsule | 1 | 2019 | 2 | 0.190 |
Why?
| | Thymidine Phosphorylase | 1 | 2020 | 12 | 0.180 |
Why?
| | NADH Dehydrogenase | 1 | 2019 | 18 | 0.180 |
Why?
| | Porencephaly | 1 | 2019 | 6 | 0.180 |
Why?
| | Collagen Type IV | 1 | 2019 | 22 | 0.170 |
Why?
| | Spectrum Analysis | 1 | 2019 | 88 | 0.170 |
Why?
| | Twins, Monozygotic | 1 | 2019 | 214 | 0.170 |
Why?
| | Biomarkers | 2 | 2024 | 3588 | 0.160 |
Why?
| | Lactic Acid | 1 | 2019 | 282 | 0.160 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 181 | 0.150 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2019 | 508 | 0.150 |
Why?
| | Cell Respiration | 2 | 2015 | 76 | 0.150 |
Why?
| | Liver | 3 | 2015 | 1816 | 0.150 |
Why?
| | Acyl-CoA Dehydrogenase | 2 | 2009 | 8 | 0.150 |
Why?
| | Dihydrolipoamide Dehydrogenase | 1 | 2016 | 7 | 0.150 |
Why?
| | Cataract | 1 | 2019 | 194 | 0.140 |
Why?
| | Gene Expression | 2 | 2015 | 1489 | 0.130 |
Why?
| | Acyl Coenzyme A | 1 | 2015 | 30 | 0.130 |
Why?
| | Introns | 1 | 2016 | 234 | 0.130 |
Why?
| | Prognosis | 2 | 2015 | 3443 | 0.130 |
Why?
| | Exons | 1 | 2016 | 307 | 0.130 |
Why?
| | Lysosomal Storage Diseases | 1 | 2015 | 4 | 0.130 |
Why?
| | Diet Therapy | 1 | 2015 | 38 | 0.130 |
Why?
| | Dyskinesias | 1 | 2015 | 11 | 0.130 |
Why?
| | COS Cells | 1 | 2015 | 184 | 0.130 |
Why?
| | Mental Retardation, X-Linked | 1 | 2015 | 13 | 0.130 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2015 | 25 | 0.130 |
Why?
| | Electron Transport | 1 | 2015 | 101 | 0.130 |
Why?
| | Cerebrospinal Fluid | 1 | 2015 | 93 | 0.130 |
Why?
| | Protein Structure, Secondary | 1 | 2015 | 338 | 0.120 |
Why?
| | Treatment Outcome | 6 | 2023 | 9342 | 0.120 |
Why?
| | Demyelinating Diseases | 1 | 2015 | 79 | 0.120 |
Why?
| | Base Sequence | 2 | 2010 | 2159 | 0.120 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 84 | 0.120 |
Why?
| | Cell Line | 1 | 2019 | 2707 | 0.120 |
Why?
| | Host Cell Factor C1 | 1 | 2013 | 8 | 0.120 |
Why?
| | Genes, X-Linked | 1 | 2013 | 17 | 0.120 |
Why?
| | Hyperhomocysteinemia | 1 | 2013 | 24 | 0.120 |
Why?
| | Genetic Testing | 1 | 2016 | 389 | 0.120 |
Why?
| | Muscles | 1 | 2015 | 333 | 0.120 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 2013 | 19 | 0.120 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2013 | 24 | 0.120 |
Why?
| | Cytochrome-c Oxidase Deficiency | 1 | 2013 | 3 | 0.120 |
Why?
| | Alleles | 1 | 2016 | 832 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 3 | 2013 | 2275 | 0.110 |
Why?
| | Atrophy | 1 | 2013 | 164 | 0.110 |
Why?
| | Electron Transport Complex II | 1 | 2013 | 24 | 0.110 |
Why?
| | Stilbenes | 1 | 2013 | 35 | 0.110 |
Why?
| | Vitamin B 12 | 1 | 2013 | 115 | 0.110 |
Why?
| | Sequence Alignment | 2 | 2015 | 336 | 0.110 |
Why?
| | Liver Transplantation | 1 | 2020 | 847 | 0.110 |
Why?
| | Quality of Life | 1 | 2023 | 2366 | 0.110 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 965 | 0.110 |
Why?
| | DNA | 1 | 2019 | 1388 | 0.110 |
Why?
| | Urea Cycle Disorders, Inborn | 1 | 2011 | 22 | 0.100 |
Why?
| | Time | 1 | 2011 | 77 | 0.100 |
Why?
| | Vitamin B 6 | 1 | 2011 | 9 | 0.100 |
Why?
| | Genetic Association Studies | 2 | 2010 | 371 | 0.100 |
Why?
| | Dietary Supplements | 1 | 2015 | 467 | 0.100 |
Why?
| | Retrospective Studies | 3 | 2019 | 12978 | 0.100 |
Why?
| | Age of Onset | 3 | 2013 | 467 | 0.100 |
Why?
| | Cystathionine beta-Synthase | 1 | 2011 | 60 | 0.100 |
Why?
| | Homocystinuria | 1 | 2011 | 63 | 0.090 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 1868 | 0.090 |
Why?
| | Diffuse Cerebral Sclerosis of Schilder | 1 | 2010 | 4 | 0.090 |
Why?
| | Sirtuin 3 | 1 | 2011 | 60 | 0.090 |
Why?
| | Prenatal Diagnosis | 1 | 2011 | 168 | 0.090 |
Why?
| | Chemokines | 1 | 2011 | 230 | 0.090 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2010 | 45 | 0.090 |
Why?
| | Adult | 6 | 2020 | 31512 | 0.090 |
Why?
| | Biogenic Monoamines | 1 | 2009 | 14 | 0.090 |
Why?
| | Leucovorin | 1 | 2009 | 43 | 0.090 |
Why?
| | Myocardium | 1 | 2015 | 970 | 0.090 |
Why?
| | Structure-Activity Relationship | 1 | 2010 | 522 | 0.090 |
Why?
| | Neonatal Screening | 1 | 2010 | 152 | 0.090 |
Why?
| | Gene Frequency | 1 | 2010 | 513 | 0.090 |
Why?
| | Pregnancy Complications | 2 | 2011 | 448 | 0.080 |
Why?
| | Sequence Deletion | 1 | 2009 | 171 | 0.080 |
Why?
| | Conserved Sequence | 1 | 2009 | 219 | 0.080 |
Why?
| | Nervous System Diseases | 1 | 2011 | 261 | 0.080 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 4552 | 0.080 |
Why?
| | Fatty Liver | 1 | 2011 | 253 | 0.080 |
Why?
| | Quality Assurance, Health Care | 1 | 2010 | 325 | 0.080 |
Why?
| | Developmental Disabilities | 1 | 2010 | 247 | 0.080 |
Why?
| | Protein Conformation | 1 | 2010 | 848 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2011 | 1384 | 0.070 |
Why?
| | Reflex, Abnormal | 1 | 2006 | 8 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2674 | 0.070 |
Why?
| | Diet | 3 | 2012 | 1153 | 0.070 |
Why?
| | Phenylalanine | 1 | 2006 | 66 | 0.070 |
Why?
| | Young Adult | 2 | 2011 | 10793 | 0.070 |
Why?
| | Tendinopathy | 1 | 2006 | 34 | 0.070 |
Why?
| | Models, Molecular | 1 | 2010 | 1435 | 0.070 |
Why?
| | Sodium Benzoate | 1 | 2005 | 5 | 0.070 |
Why?
| | Follow-Up Studies | 2 | 2011 | 4596 | 0.070 |
Why?
| | Amino Acid Oxidoreductases | 1 | 2005 | 21 | 0.070 |
Why?
| | Transferases | 1 | 2005 | 27 | 0.060 |
Why?
| | Kinetics | 1 | 2008 | 1624 | 0.060 |
Why?
| | Psychomotor Disorders | 1 | 2004 | 18 | 0.060 |
Why?
| | Syndrome | 1 | 2006 | 344 | 0.060 |
Why?
| | Motor Skills Disorders | 1 | 2005 | 19 | 0.060 |
Why?
| | Physicians | 1 | 2013 | 794 | 0.060 |
Why?
| | Multienzyme Complexes | 1 | 2005 | 64 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2013 | 4077 | 0.060 |
Why?
| | Practice Patterns, Physicians' | 1 | 2013 | 1200 | 0.060 |
Why?
| | Merozoite Surface Protein 1 | 1 | 2023 | 2 | 0.060 |
Why?
| | Stereoisomerism | 1 | 2003 | 93 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 1012 | 0.060 |
Why?
| | Circadian Rhythm | 1 | 2006 | 401 | 0.050 |
Why?
| | Lower Extremity | 1 | 2006 | 335 | 0.050 |
Why?
| | Anti-Infective Agents | 1 | 2005 | 227 | 0.050 |
Why?
| | Biopsy | 1 | 2005 | 1079 | 0.050 |
Why?
| | Pregnancy | 2 | 2011 | 5691 | 0.050 |
Why?
| | Fatigue | 1 | 2023 | 297 | 0.050 |
Why?
| | Pipecolic Acids | 2 | 2012 | 22 | 0.050 |
Why?
| | Cognition | 2 | 2022 | 1024 | 0.050 |
Why?
| | Colorado | 1 | 2010 | 4196 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2005 | 726 | 0.050 |
Why?
| | Thymidine | 1 | 2020 | 62 | 0.050 |
Why?
| | Muscle, Skeletal | 2 | 2010 | 1515 | 0.050 |
Why?
| | Esophageal Motility Disorders | 1 | 2020 | 24 | 0.050 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2020 | 122 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1687 | 0.040 |
Why?
| | Animals | 3 | 2015 | 33381 | 0.040 |
Why?
| | Age Factors | 1 | 2005 | 2995 | 0.040 |
Why?
| | Models, Biological | 1 | 2005 | 1715 | 0.040 |
Why?
| | Enoyl-CoA Hydratase | 1 | 2015 | 9 | 0.030 |
Why?
| | Aminoacylation | 1 | 2015 | 12 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 540 | 0.030 |
Why?
| | Delphi Technique | 1 | 2014 | 164 | 0.030 |
Why?
| | RNA, Transfer | 1 | 2015 | 119 | 0.030 |
Why?
| | Middle Aged | 2 | 2023 | 27617 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 6412 | 0.030 |
Why?
| | Neuroglia | 1 | 2015 | 157 | 0.030 |
Why?
| | Exome | 1 | 2015 | 220 | 0.030 |
Why?
| | Myelin Sheath | 1 | 2015 | 148 | 0.030 |
Why?
| | Electron Transport Complex IV | 1 | 2013 | 53 | 0.030 |
Why?
| | Citrate (si)-Synthase | 1 | 2013 | 49 | 0.030 |
Why?
| | North America | 1 | 2013 | 266 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 311 | 0.030 |
Why?
| | Consensus | 1 | 2014 | 534 | 0.030 |
Why?
| | Chemokine CCL4 | 1 | 2011 | 21 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 564 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 625 | 0.020 |
Why?
| | Betaine | 1 | 2011 | 64 | 0.020 |
Why?
| | Northwestern United States | 1 | 2010 | 56 | 0.020 |
Why?
| | Interleukin-1alpha | 1 | 2011 | 56 | 0.020 |
Why?
| | Southwestern United States | 1 | 2010 | 94 | 0.020 |
Why?
| | Aged | 1 | 2009 | 19657 | 0.020 |
Why?
| | Interleukin-17 | 1 | 2011 | 105 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2014 | 693 | 0.020 |
Why?
| | Patient Care Management | 1 | 2010 | 57 | 0.020 |
Why?
| | Public Health Practice | 1 | 2010 | 62 | 0.020 |
Why?
| | DNA Polymerase gamma | 1 | 2010 | 7 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2013 | 377 | 0.020 |
Why?
| | Acetylation | 1 | 2011 | 217 | 0.020 |
Why?
| | Binding Sites | 1 | 2013 | 1224 | 0.020 |
Why?
| | Family Health | 1 | 2010 | 201 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2011 | 379 | 0.020 |
Why?
| | Information Dissemination | 1 | 2010 | 210 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2010 | 408 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 2010 | 187 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 1975 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2011 | 477 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2010 | 681 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2011 | 688 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1795 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2009 | 421 | 0.020 |
Why?
| | Linear Models | 1 | 2009 | 827 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2011 | 1171 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2013 | 2657 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2011 | 2025 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2012 | 2513 | 0.020 |
Why?
| | Myoclonic Epilepsy, Juvenile | 1 | 2004 | 1 | 0.020 |
Why?
| | Agenesis of Corpus Callosum | 1 | 2004 | 12 | 0.020 |
Why?
| | Nystagmus, Pathologic | 1 | 2004 | 7 | 0.020 |
Why?
| | Proteomics | 1 | 2011 | 876 | 0.020 |
Why?
| | Apnea | 1 | 2004 | 16 | 0.020 |
Why?
| | Mice | 2 | 2011 | 15520 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2011 | 2680 | 0.020 |
Why?
| | Hydrocephalus | 1 | 2004 | 81 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 2874 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2445 | 0.010 |
Why?
| | Health Surveys | 1 | 2004 | 454 | 0.010 |
Why?
| | Survival Analysis | 1 | 2004 | 1267 | 0.010 |
Why?
| | Respiration, Artificial | 1 | 2004 | 545 | 0.010 |
Why?
| | Sex Factors | 1 | 2004 | 1781 | 0.010 |
Why?
| | Disease Progression | 1 | 2004 | 2490 | 0.010 |
Why?
| | Registries | 1 | 2004 | 1810 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2004 | 4708 | 0.010 |
Why?
|
|
Van Hove's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|